Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extension of the RENACER Study: 12-Month Efficacy, Safety and Certolizumab PEGol Survival in 501 Rheumatoid Arthritis Patients.
Torrente-Segarra V, Fernández Prada M, Expósito R, Garrido Puñal NP, Sánchez-Andrade A, Lamúa-Riazuelo JR, Olivé A, Tovar JV; RENACER Study Group. Torrente-Segarra V, et al. Reumatol Clin (Engl Ed). 2021 Jan;17(1):57-58. doi: 10.1016/j.reuma.2018.12.004. Epub 2019 Jan 28. Reumatol Clin (Engl Ed). 2021. PMID: 30704922 Free article. English, Spanish. No abstract available.
Belimumab in subacute cutaneous lupus erythematosus.
Torrente-Segarra V, Peramiquel L, Bonet M. Torrente-Segarra V, et al. Lupus. 2021 Oct;30(12):2017-2018. doi: 10.1177/09612033211033989. Epub 2021 Jul 20. Lupus. 2021. PMID: 34284673 No abstract available.
Apremilast Use in Oligoarticular Psoriatic Arthritis.
Torrente-Segarra V, Bonet M. Torrente-Segarra V, et al. J Rheumatol. 2022 Nov;49(11):1293-1294. doi: 10.3899/jrheum.211227. Epub 2022 Jun 1. J Rheumatol. 2022. PMID: 35649545 No abstract available.
Sjögren's syndrome-associated interstitial lung disease: A multicenter study.
Reina D, Roig Vilaseca D, Torrente-Segarra V, Cerdà D, Castellví I, Díaz Torné C, Moreno M, Narváez J, Ortiz V, Blavia R, Martín-Baranera M, Corominas H. Reina D, et al. Reumatol Clin. 2016 Jul-Aug;12(4):201-5. doi: 10.1016/j.reuma.2015.09.003. Epub 2015 Nov 11. Reumatol Clin. 2016. PMID: 26573882 Free article. English, Spanish.
VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
Torrente-Segarra V, Acosta Pereira A, Morla R, Ruiz JM, Clavaguera T, Figuls R, Corominas H, Geli C, Roselló R, de Agustín JJ, Alegre C, Pérez C, García A, Rodríguez de la Serna A. Torrente-Segarra V, et al. Reumatol Clin. 2016 Nov-Dec;12(6):319-322. doi: 10.1016/j.reuma.2015.11.019. Epub 2016 Jan 29. Reumatol Clin. 2016. PMID: 26831256 Free article. English, Spanish.
68 results